Onyx Scientific

Activities: Manufacturing Ingredients Regulatory Research & Development

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    PROTACs: current landscape and their significance in drug discovery PROteolysis TArgeting Chimeras (PROTACs) represent a revolutionary approach to drug discovery that leverages their chemically induced proximity to degrade disease-causing...
  2. Orphan drug sales will continue to rise, 2025 Evaluate report notes The 2025 Orphan Drug Report notes that orphan drugs will likely make $320bn by 2030, with Johnson & Johnson taking $31.7bn of this
  3. GF Piping Systems introduces its corrosive waste piping solution FUSEAL in the UK FUSEAL products feature a high chemical resistance as well as physical properties that make them ideal for handling special waste mixtures of acids, bases and solvents
  4. At China International Medical Equipment Fair, TekniPlex Healthcare to feature robust radiation-sterilisable PVC compounds Company also will showcase tracheal tube balloon compounds with patient-centric properties, as well as extensive PTA/PTCA balloon catheter tubing capabilities
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Navigating ESG challenges in pharma and logistics: the road to sustainability Jake Brown, Commercial Lead at LogiPharma, discusses the upcoming 25th edition of the conference and how some of its key sponsors are navigating ESG challenges

Upcoming event

Interphex

1–3 April 2025 | Conference and Exhibition | New York, US See all

Related Content

Marketing

Onyx Scientific aims for European growth with new BD hire

Leading small molecule CDMO Onyx Scientific has its sights set on European-wide commercial expansion with the new appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe
Marketing

Onyx Scientific targets stateside expansion with new appointment

Leading small molecule CDMO Onyx Scientific is set to expand its commercial operations in the United States with the appointment of Anthony Harbour as Business Development Manager in North America to lead the company's ambitious US growth plans
Manufacturing

Onyx completes second phase of CMC expansion

The investment increases the facility’s capabilities to support its customers in CMC services and adds further strength to its UK manufacturing
Manufacturing

Onyx Scientific opens second small molecule site

Commercial manufacturing approval has been granted by the MHRA for the site
Regulatory

Onyx Scientific receives commercial API license

The license allows the company to support API projects from pre-clinical studies to low volume commercial manufacture
Manufacturing

Onyx Scientific makes $3.96m UK facility investment

The facility is expected to be approximately 30,000 sqft and will be used for non-GMP & GMP Phase I – III and commercial API manufacturing
Manufacturing

Onyx Scientific eyes UK facility expansion for commercial API licence

Licence approval from the MHRA is expected this year and will see the British CRO take customers’ projects from concept to market
Subscribe now